Tata Memorial study finds Nimotuzumab significantly increases survival in head and neck cancer
DailyMirror.News, Mumbai, July 31, 2024: A study conducted by Tata Memorial Hospital in Mumbai has shown that adding Nimotuzumab to the standard treatment